STANFORD, Calif.--(BUSINESS WIRE)--Physicians and policy-makers know that drugs are frequently prescribed to treat certain diseases despite a lack of FDA approval—a practice known as off-label prescribing. Yet they say the problem is so big they don’t know how to begin tackling it.
